期刊文献+

胰淀素与2型糖尿病 被引量:1

下载PDF
导出
摘要 胰岛淀粉样蛋白沉积和β细胞团减少是 2型糖尿病 (DM)的病理特征。胰岛 β细胞分泌的胰淀素是胰岛淀粉样蛋白的主要成分 ,最近研究表明 ,胰淀素能诱导胰岛 β细胞凋亡并在胰岛素抵抗、磺脲类药物继发失效等方面具有一定作用 ,其类似物普兰林格 (Pramlintide)对胃排空的作用正用于临床。胰淀素形成的胰岛淀粉样蛋白沉积引起胰岛 β细胞功能障碍 ,在 2型DM的发生、发展中具有重要作用。因此抑制淀粉样蛋白形成 ,作为治疗 2型DM的方向是很有前景的。
出处 《国外医学(内分泌学分册)》 2005年第1期27-29,共3页 Foreign Medical Sciences(Section of Endocrinology)
基金 天津市自然科学基金项目 (993 60 5 111)
  • 相关文献

参考文献21

  • 1Hayden MR, Tyagi SC. "A" is for amylin and amyloid in type 2 diabetes mellitus. JOP,2001,2:124-139.
  • 2Hoppener WM, Ahern B, Lips C J, et al. Islet amyloid and type 2 diabetes mellitus. New Engl J Med,2000,343:411-419.
  • 3Gebre Medhin S, Olofsson C, Mulder H. Islet amyloid polypeptide in the islets of langerhans: friend or foe? Diabetologia,2000,43:687-695.
  • 4Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes,2003,52:102-110.
  • 5Ritzel RA, Butler PC. Replication increases beta-cell vulnerability to human islet amyloid polypeptide-induced apoptosis. Diabetes, 2003,52:1701-1708.
  • 6ButlerAE,JangJ,GurloT, etal. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide(HIP Rat):a new model for type 2 diabetes. Diabetes,2004,53:1509-1516.
  • 7Saafi EL, Konarkowska B, Zhang S, et al. Ultrastructural evidence that apoptosis is the mechanism by which human amylin evokes death in RINm5F pancreatic islet beta-cells. Cell Biol Int,2001,25: 339-350.
  • 8Butler AE, Janson J, Soeller WC, et al. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes,2003,52:2304-2314.
  • 9Chandra J, Zhivotovsky B, Zaitsev S, et al. Role of apoptosis in pancreatic beta-cell death in diabetes. Diabetes, 2001,50:S44-S47.
  • 10Janson J, Ashley RH, Harrison D, et al. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes, 1999,48: 491-498.

二级参考文献8

  • 1何戎华.磺脲类降糖药治疗失效研究进展[J].国外医学(内分泌学分册),1995,15(2):81-83. 被引量:10
  • 2黄丹珊.胰淀素对磺脲类口服降糖药的抑制效应.全国首届内分泌专业中青年论文交流会汇编[M].北京:-,1994.194-196.
  • 3向红丁.磺脉类降糖药对HIT细胞胰岛素分泌刺激作用的分子机制研究[J].中国糖尿病杂志,1994,2:34-37.
  • 4何戎华,国外医学.内分泌学分册,1995年,15卷,81页
  • 5黄丹珊,全国首届内分泌专业中青年论文交流会汇编,1994年,194页
  • 6向红丁,中国糖尿病杂志,1994年,2卷,34页
  • 7钱玉宁,中国糖尿病杂志,1993年,1卷,21页
  • 8钱玉宁,贾培红,黄丹珊,王淑风,施曼珠,钱荣立.胰淀素对大鼠糖代谢和胰岛素分泌功能的影响[J].中国糖尿病杂志,1993,1(1):22-25. 被引量:5

共引文献15

同被引文献22

  • 1付方明,李利平,董砚虎.胰淀素研究新进展[J].国外医学(内科学分册),2004,31(5):191-193. 被引量:4
  • 2黄志宏,高燕燕.胰淀素与代谢综合征[J].国外医学(内分泌学分册),2005,25(4):246-248. 被引量:2
  • 3林毅,彭永德.胰淀素类似物普兰林肽[J].世界临床药物,2006,27(11):673-676. 被引量:3
  • 4蔡乐,朱珠,王强,刘新月.胰岛素类似物与新型降糖激素类药物[J].中国新药杂志,2007,16(6):432-437. 被引量:26
  • 5Ryan G,Briscoe TA,Jobe L.Review of pramlinfide as adjunctive therapy in treatment of typel and type2 diabetes[J].Drug Design Development and Therapy,2008,2(1):203-214.
  • 6Vlieghe P, Lisowski V, Martinez J,et al.Synthetic therapeutic peptides:science and market[J]. Drug Discorvery Today,2010,15( 1 ):40-56.
  • 7Fineman M,Weyer C,Maggs DG,et al.The human amylin analogue,pramlintide,reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus[J].Horm Metab Res,2002,3(4): 504-508.
  • 8Levetan C,Want LL,Weyer C,et al.Impact of pramlintide on glucose fluctuations and postprandial glucose, and triglyceride excursions anaong patients with type 1 diabetes intensively treated with insulin pumps[J].Diabetes Care,2003,2(6): 1-8.
  • 9Fineman MS,Koda JE,Shen LZ,et al.The human amylin anaiogue,pramlintide,corrects postprandial hyperglucagonemia in patients with type 1 diabetes[J].Metabosim,2002,51(5):636-641.
  • 10Velh A.Lee JS,Camilleri M,et al.Effects of pramlinfide,an amylin analogue on gastric emptying in type 1 and 2 diabetes mellitus[J]. Neurogastrenteml Motil,2002,14(2): 123-131.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部